We can classify fats by their chemical structure, with some having no double bonds (saturated fats), and some having at least one double bond (a mono-unsaturated fat) or more than one double bond (a polyunsaturated fat)
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription
We asked a nationally representative sample of nearly 9,000 adults about their experience with these drugs.Women tend to use GLP-1 drugs at higher rates than men
Most Medicare and other insurance plans typically provide coverage for well-known GLP-1 agonists like Ozempic, Trulicity, and Victoza
Nutrition tracking: Log your food & water to stay on track
By addressing multiple metabolic pathways, Retatrutide offers a comprehensive solution for improving cardiometabolic measures
.webp)
